A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group on the African continent. In 2023, more ...

Rhetoric from the White House risks growing misconceptions of what harm reduction is and, significantly, what it is not.

The Trump administration’s dismantling of USAID has put more than 8,000 health workers in South Africa’s national HIV program ...

A vending machine outside an Asbury Park clinic carries syringes, kits for using crack and Narcan to fight overdoses. It's designed to save lives.

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

Scientists have discovered a promising new therapy for resistant high blood pressure, leading to a 15-point drop in systolic ...

Researchers have identified a never-before-seen mechanism that enables HIV-1 to evade the body's natural defenses and use it to support its survival and replication. The 'loophole' is a biological ...